Mid-Morning Market Update: Markets Open Lower; Carnival Reports Downbeat Q4 Revenue

Following the market opening Monday, the Dow traded down 1.58% to 34,806.55 while the NASDAQ fell 1.40% to 14,956.74. The S&P also fell, dropping 1.40% to 4,555.91.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 51,765,710 cases with around 827,320 deaths. India confirmed a total of at least 34,746,830 cases and 477,550 deaths, while Brazil reported over 22,213,760 COVID-19 cases with 617,830 deaths. In total, there were at least 275,075,790 cases of COVID-19 worldwide with more than 5,372,280 deaths.


Leading and Lagging Sectors


Consumer staples shares fell by just 0.4% on Monday. Meanwhile, top gainers in the sector included Dingdong (Cayman) Limited DDL, up 6% and Local Bounti Corporation LOCL up 4%.


In trading on Monday, materials shares tumbled 2.4%.


Top Headline


Carnival Corp CCL reported weaker-than-expected revenue for its fourth quarter.

The cruise operator's quarterly revenue rose to $1.29 billion from $34 million in the year-ago period. However, analysts were expecting revenue of $1.41 billion. Carnival posted quarterly adjusted net loss of $2 billion.


Equities Trading UP


Society Pass Incorporated SOPA shares shot up 126% to $7.48 after the company was added to the Russell 2000.


Shares of Bluerock Residential Growth REIT, Inc. BRG got a boost, shooting 71% to $26.43. Blackstone agreed to buy Bluerock Residential Growth REIT in a deal valued at $3.6 billion, extending its push into U.S. rental housing.


Verso Corporation VRS shares were also up, gaining 34% to $26.94 after the company announced it would be acquired by BillerundKorsnas for $27 per share.


Check out these big movers of the day


Equities Trading DOWN

Summit Therapeutics Inc. SMMT shares tumbled 46% to $2.6755 after reporting topline results for Phase III Ri-CoDIFy study for C. Difficile infection. The company said Ri-CoDIFy did not meet primary endpoint.


Shares of Spruce Biosciences, Inc. SPRB were down 24% to $3.8292. Spruce Biosciences shares jumped more than 102% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.


Bellerophon Therapeutics, Inc. BLPH was down, falling 21% to $2.5108. Bellerophon Therapeutics jumped around 35% on Friday after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc)..


Commodities

In commodity news, oil traded down 5.2% to $67.16, while gold traded down 0.5% to $1,795.50.


Silver traded down 1.4% Monday to $22.22 while copper fell 0.2% to $4.2845.


Euro zone

European shares were lower today. The eurozone’s STOXX 600 declined 1.5%, the Spanish Ibex Index fell 1.2% and the German DAX 30 dipped 1.9%. Meanwhile, the London’s FTSE 100 dropped 1.1%, French CAC 40 fell 1.1% and Italy’s FTSE MIB dipped 2%.

The Eurozone current account surplus shrank to EUR 20.5 billion in October from EUR 31 billion in the year-ago period. The goods surplus, meanwhile, narrowed to EUR 17.8 billion from EUR 39 billion.


Economics


The index of leading economic indicators rose 1.1% for November, versus analysts’ expectations for a 0.8% growth.


The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.

Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Morning Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!